hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 10:59:27 - browse：49

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Medicare drug price negotiation’s day in court

WSS

The real point of Kenneth Smith’s execution by nitrogen gas

Apple Vision Pro: A first look at health apps on the new VR headset

FDA's Pazdur wants cancer trials to range beyond China alone

ASCO: Palliative care found as helpful given virtually as in person

Juul spent big to court Black leaders to promote its e

Ultragenyx gene therapy for rare liver ailment succeeds in late

focus

hotspot

explore

23andMe had bad news about my health. I wish a person had delivered it

Shifting the focus from loneliness to social health

Drug repurposing or repositioning? The language matters

Cybersecurity threat forces Lurie Children's to take systems offline

DIEP, the 'gold standard' of breast reconstruction, is under threat

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Heart attack and stroke risk calculators need revising

Change Healthcare can notify patients about the breach, HHS says

Moonlake's readout produced a cash windfall. Risks remain

SAMSHA loosens regulations on methadone treatment centers

knowledge

Biden administration opens offers in Medicare drug price negotiations

How to increase colonoscopy rates? Looks like an AI can help

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Shifting the focus from loneliness to social health

ASCO: Palliative care found as helpful given virtually as in person

The lessons of Aduhelm, an Alzheimer's drug that was not to be

entertainment

focus

leisure time

leisure time